Medical Genetics Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy.
Neurogenetics. 2010 Feb;11(1):73-80. doi: 10.1007/s10048-009-0204-2. Epub 2009 Jul 7.
Schwannomatosis (MIM 162091) is a condition predisposing to the development of central and peripheral schwannomas; most cases are sporadic without a clear family history but a few families with a clear autosomal dominant pattern of transmission have been described. Germline mutations in SMARCB1 are associated with schwannomatosis. We report a family with multiple schwannomas and meningiomas. A SMARCB1 germline mutation in exon 1 was identified. The mutation, c.92A>T (p.Glu31Val), occurs in a highly conserved amino acid in the SMARCB1 protein. In addition, in silico analysis demonstrated that the mutation disrupts the donor consensus sequence of exon 1. RNA studies verified the absence of mRNA transcribed by the mutant allele. This is the first report of a SMARCB1 germline mutation in a family with schwannomatosis characterized by the development of multiple meningiomas.
神经鞘瘤病(MIM 162091)是一种易患中枢和外周神经鞘瘤的疾病;大多数病例为散发性,无明确家族史,但也有少数家族呈明确常染色体显性遗传模式。SMARCB1 的种系突变与神经鞘瘤病有关。我们报告了一个有多发性神经鞘瘤和脑膜瘤的家族。在第 1 外显子中发现了 SMARCB1 种系突变。该突变,c.92A>T(p.Glu31Val),发生在 SMARCB1 蛋白高度保守的氨基酸上。此外,计算机分析表明该突变破坏了第 1 外显子的供体保守序列。RNA 研究证实了突变等位基因转录的 mRNA 缺失。这是第一个报告在一个家族中发现 SMARCB1 种系突变与多发性脑膜瘤相关的神经鞘瘤病。